Daxysac 200mg Tablet

Daxysac 200 mg Tablet is a prescription medicine used for the long-term treatment of chronic heart failure with reduced ejection fraction (HFrEF) in adults. It combines Sacubitril, a neprilysin inhibitor, and Valsartan, an angiotensin II receptor blocker (ARB), to improve heart function and reduce the workload on the heart. This combination helps the heart pump blood more efficiently by relaxing blood vessels, reducing fluid retention, and lowering blood pressure. Daxysac significantly reduces the risk of hospitalization due to heart failure and cardiovascular death, while helping relieve symptoms such as shortness of breath, fatigue, swelling of the legs, and reduced exercise tolerance. It is usually prescribed as part of a comprehensive heart failure management plan that includes lifestyle modifications, regular monitoring, and other heart medications when needed. Consistent use under medical supervision helps improve heart performance, daily functioning, and overall quality of life.

Daxysac 200 mg Tablet contains Sacubitril 97 mg and Valsartan 103 mg, a combination specifically developed for managing chronic heart failure with reduced ejection fraction. Sacubitril inhibits the neprilysin enzyme, increasing beneficial natriuretic peptides that relax blood vessels, remove excess sodium and water, reduce fluid overload, and decrease stress on the heart. Valsartan, an angiotensin II receptor blocker (ARB), blocks the effects of angiotensin II, preventing blood vessel narrowing and reducing blood pressure and fluid retention.

Together, these actions improve the heart's pumping efficiency, relieve symptoms such as breathlessness, fatigue, and swelling, and significantly lower the risk of hospitalization and cardiovascular death. Long-term therapy slows the progression of heart failure and improves exercise tolerance and overall physical functioning. Combined with a heart-healthy lifestyle, reduced salt intake, regular medical follow-up, and adherence to prescribed treatment, Daxysac helps maintain better cardiovascular health and improves the patient's quality of life.

Precaution

• Use only under medical supervision.
• Do not use during pregnancy, as it may seriously harm the unborn baby.
• Inform your doctor if you have kidney disease, liver disease, low blood pressure, or a history of angioedema.
• Avoid potassium supplements or potassium-containing salt substitutes unless advised.
• Regular monitoring of blood pressure, kidney function, and potassium levels is recommended.
• A 36-hour washout period is required when switching from an ACE inhibitor to reduce the risk of angioedema.

Storage

• Store below 30°C.
• Keep in a cool, dry place.
• Protect from moisture and direct sunlight.
• Keep the tablets in their original packaging.
• Keep out of reach of children.